A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes
| Image |  |
|---|---|
| Description | scientific article published on 01 March 2020 |
| Author/s |
author: Jan W Eriksson Hiddo J L Heerspink Skander Mulder Sunil B Nagaraj |
| Publication date | March 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |